Back | Next |
home / stock / xoma / xoma message board
Subject | By | Source | When |
---|---|---|---|
daily looks nice but we should know by | my name is | investorshub | 04/19/2018 12:25:14 AM |
News ? Xoma | highstakes | investorshub | 04/18/2018 3:14:21 PM |
what a pumper | my name is | investorshub | 04/07/2018 2:05:01 AM |
What is this news ? | highstakes | investorshub | 04/06/2018 1:35:21 PM |
Volume shows a steady rise up Xoma | highstakes | investorshub | 04/05/2018 2:01:57 PM |
geeze now I really want to buy this stock | my name is | investorshub | 03/28/2018 1:59:35 AM |
looks like a lot of dilution coming | jdlamont | investorshub | 03/28/2018 1:37:22 AM |
Its at the red line Xoma | highstakes | investorshub | 03/17/2018 10:23:22 AM |
there could still be money to be made | my name is | investorshub | 03/09/2018 2:44:34 AM |
Market is correcting. Will be a rockey year. | highstakes | investorshub | 03/09/2018 1:50:14 AM |
bought at 22.78. this was uncalled for drop. | jdlamont | investorshub | 03/08/2018 9:18:19 PM |
Up 7.8%. That was the highest gain on | WovenO2 | investorshub | 03/08/2018 4:03:13 AM |
Needs to stay above 200 day. As | WovenO2 | investorshub | 03/07/2018 1:47:08 PM |
chart is starting look interesting again but I | my name is | investorshub | 03/07/2018 1:55:00 AM |
IF any of xoma's clients come up with | jdlamont | investorshub | 03/03/2018 2:22:57 AM |
I tend to agree. The big $$$$$ | WovenO2 | investorshub | 02/13/2018 9:10:04 PM |
being as i ended up so much ive | my name is | investorshub | 02/13/2018 6:03:03 PM |
What reentry would you consider? | WovenO2 | investorshub | 02/13/2018 5:29:12 PM |
biowatcher: This would be a good time to consider a position. ER on the 9th | biowatcher | investorshangout | 03/05/2016 5:00:55 PM |
Hattlem: Dumped it all @ 1.91, and will buy it again on the dip, and sell again on the rip. | Hattlem | investorshangout | 11/03/2015 3:56:17 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-07-05 16:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
EMERYVILLE, Calif., June 12, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today it has received an $8.1 million milestone payment from Viracta Therapeutics, Inc., related to Day One Biopharmaceuticals’ recent sale of its Priority Revie...
2024-06-04 04:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...